Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96fc9b738ef2772a43c5d2cf2d9d8c19 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6043 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-292 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29 |
filingDate |
2001-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_631835b388746e66fbb92e96c09c150f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08b93c29ba6101972f88063331709c61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41db8416403eb714f093fe0f7dc67b21 |
publicationDate |
2003-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1308462-A1 |
titleOfInvention |
Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof |
abstract |
The present invention provides a kind of HBV-antigen bound to heat shocknproteins(hsps) which comprises core antigen, surface antigen and polymerasenantigen. The present invention also provides a complex of HBV antigen bound tonheat shock protein gp96 and hsp78, as well as a method for preparing the complex.nThe complex includes a complex of gp96 and hsp78 non-covalently bound tonantigenic polypeptide, as well as a fusion protein of both which results from covalentnbinding. Such complex can be used to prepare therapeutic vaccine for treatingnhepatitis B and primary hepatocellular carcinoma. |
priorityDate |
2000-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |